EMHTF - Emerald Health Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
8,040
1,948
938
253
31
Cost of Revenue
14,693
5,048
1,223
603
204
Gross Profit
-6,838
-3,099
-286
-350
-173
Operating Expenses
Research Development
2,854
801
208
302
162
Selling General and Administrative
37,087
30,448
7,295
2,133
3,116
Total Operating Expenses
42,448
34,245
8,811
2,551
3,325
Operating Income or Loss
-49,286
-37,344
-9,097
-2,901
-3,497
Interest Expense
-
219
0
40
-
Total Other Income/Expenses Net
23,905
5,370
94
40
0
Income Before Tax
-24,135
-31,007
-8,842
-2,941
-3,497
Income Tax Expense
294
-24
0
0
-
Income from Continuing Operations
-24,428
-30,983
-8,842
-2,941
-3,497
Net Income
-23,965
-30,577
-8,732
-2,941
-3,497
Net Income available to common shareholders
-23,965
-30,577
-8,732
-2,941
-3,497
Reported EPS
Basic
-
-0.22
-0.10
-0.05
-0.08
Diluted
-
-0.22
-0.10
-0.05
-0.08
Weighted average shares outstanding
Basic
-
141,443
88,448
54,265
46,071
Diluted
-
141,443
88,448
54,265
46,071
EBITDA
-
-27,341
-8,559
-2,784
-3,451